1. Rattanakaemakorn, P, Chevaisrakul, P, Wongpraparut, C, Chiowchanwisawakit, P, Tovanabutra, N, Tantiwong, P et al.. Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study. Dermatol Ther (Heidelb). 2024;14 (12):3229-3241. doi: 10.1007/s13555-024-01299-6. PubMed PMID:39505788 PubMed Central PMC11604867.
  2. Khampaen, T, Kafaksom, T, Dechapaphapitak, N, Tongdee, N, Chevaisrakul, P. Correlations among quality of life, spinal mobility, and disease activity in early-treated axial spondyloarthritis: a single-center cross-sectional study. BMC Rheumatol. 2024;8 (1):54. doi: 10.1186/s41927-024-00426-2. PubMed PMID:39415300 PubMed Central PMC11481462.
  3. Chevaisrakul, P, Lumjiaktase, P, Kietdumrongwong, P, Chuatrisorn, I, Chatsangjaroen, P, Phanuphak, N et al.. Hybrid and herd immunity 6 months after SARS-CoV-2 exposure among individuals from a community treatment program. Sci Rep. 2023;13 (1):763. doi: 10.1038/s41598-023-28101-5. PubMed PMID:36641523 PubMed Central PMC9840162.
  4. Harindhanavudhi, T, Areevut, C, Sahakitrungruang, T, Tharavanij, T, Kietdumrongwong, P, Ngimruksa, O et al.. Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience. J Diabetes Investig. 2022;13 (8):1448-1457. doi: 10.1111/jdi.13804. PubMed PMID:35394118 PubMed Central PMC9114836.
  5. Sun, X, Li, R, Cai, Y, Al-Herz, A, Lahiri, M, Choudhury, MR et al.. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region. Lancet Reg Health West Pac. 2021;15 :100240. doi: 10.1016/j.lanwpc.2021.100240. PubMed PMID:34528015 PubMed Central PMC8365438.
  6. Kanjana, K, Chevaisrakul, P, Matangkasombut, P, Paisooksantivatana, K, Lumjiaktase, P. Inhibitory activity of FOXP3+ regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis. Sci Rep. 2020;10 (1):19789. doi: 10.1038/s41598-020-76168-1. PubMed PMID:33188235 PubMed Central PMC7666192.
  7. Kanjana, K, Chevaisrakul, P, Matangkasombut, P, Paisooksantivatana, K, Lumjiaktase, P. Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study. Front Med (Lausanne). 2020;7 :25. doi: 10.3389/fmed.2020.00025. PubMed PMID:32118010 PubMed Central PMC7011614.
  8. Kanjana, K, Paisooksantivatana, K, Matangkasombut, P, Chevaisrakul, P, Lumjiaktase, P. Efficient short-term expansion of human peripheral blood regulatory T cells for co-culture suppression assay. J Immunoassay Immunochem. 2019;40 (6):573-589. doi: 10.1080/15321819.2019.1659813. PubMed PMID:31460830 .
  9. Yongchairat, K, Tanboon, J, Waisayarat, J, Narongroeknawin, P, Chevaisrakul, P, Dejthevaporn, C et al.. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study. Clin Rheumatol. 2019;38 (12):3459-3469. doi: 10.1007/s10067-019-04756-2. PubMed PMID:31446540 .
  10. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  11. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2018;21 (1):170-178. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  12. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  13. Reutrakul, S, Thakkinstian, A, Anothaisintawee, T, Chontong, S, Borel, AL, Perfect, MM et al.. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23 :26-45. doi: 10.1016/j.sleep.2016.03.019. PubMed PMID:27692274 PubMed Central PMC9554893.
  14. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  15. Lau, CS, Chia, F, Harrison, A, Hsieh, TY, Jain, R, Jung, SM et al.. APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis. 2015;18 (7):685-713. doi: 10.1111/1756-185X.12754. PubMed PMID:26334449 .
  16. Pitipakorn, U, Suwannalai, P, Trachoo, O, Rattanasiri, S, Chitphuk, S, Ngamjanyaporn, P et al.. Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus. Int J Rheum Dis. 2016;19 (7):693-9. doi: 10.1111/1756-185X.12609. PubMed PMID:26200015 .
  17. Wacharapornin, P, Suwannalai, P. Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs. J Med Assoc Thai. 2014;97 (11):1157-63. . PubMed PMID:25675680 .
  18. Navarra, SV, Tang, B, Lu, L, Lin, HY, Mok, CC, Asavatanabodee, P et al.. Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia. Int J Rheum Dis. 2014;17 (3):291-8. doi: 10.1111/1756-185X.12188. PubMed PMID:24131578 PubMed Central PMC4034594.
  19. Suwannalai, P, Britsemmer, K, Knevel, R, Scherer, HU, Levarht, EW, van der Helm-van Mil, AH et al.. Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2014;73 (1):270-6. doi: 10.1136/annrheumdis-2012-202615. PubMed PMID:23463689 .
  20. Suwannalai, P, van de Stadt, LA, Radner, H, Steiner, G, El-Gabalawy, HS, Zijde, CM et al.. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2012;64 (5):1323-8. doi: 10.1002/art.33489. PubMed PMID:22130974 .
  21. Suwannalai, P, Willemze, A, van Toorn, L, Stoeken-Rijsbergen, G, Levarht, N, Drijfhout, JW et al.. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA. Arthritis Res Ther. 2011;13 (6):R195. doi: 10.1186/ar3524. PubMed PMID:22129077 PubMed Central PMC3334645.
  22. Shi, J, Knevel, R, Suwannalai, P, van der Linden, MP, Janssen, GM, van Veelen, PA et al.. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011;108 (42):17372-7. doi: 10.1073/pnas.1114465108. PubMed PMID:21987802 PubMed Central PMC3198314.
  23. Vananuvat, P, Suwannalai, P, Sungkanuparph, S, Limsuwan, T, Ngamjanyaporn, P, Janwityanujit, S et al.. Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Semin Arthritis Rheum. 2011;41 (3):497-502. doi: 10.1016/j.semarthrit.2011.05.004. PubMed PMID:21959291 .
  24. Suwannalai, P, Trouw, LA, Toes, RE, Huizinga, TW. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol. 2012;22 (1):15-20. doi: 10.1007/s10165-011-0486-8. PubMed PMID:21732051 .
  25. Suwannalai, P, Scherer, HU, van der Woude, D, Ioan-Facsinay, A, Jol-van der Zijde, CM, van Tol, MJ et al.. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann Rheum Dis. 2011;70 (2):373-9. doi: 10.1136/ard.2010.135509. PubMed PMID:21068094 .
  26. Suwannalai, P, Auethavekiat, P, Udomsubpayakul, U, Janvitayanujit, S. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Int J Rheum Dis. 2009;12 (2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x. PubMed PMID:20374328 .
  27. Vanichapuntu, M, Phuekfon, P, Suwannalai, P, Verasertniyom, O, Nantiruj, K, Janwityanujit, S et al.. Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?. Rheumatol Int. 2010;30 (6):755-9. doi: 10.1007/s00296-009-1058-5. PubMed PMID:19597732 .
  28. Jaovisidha, S, Denprechawong, R, Suwannalai, P, Janwityanujit, S. Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital. J Med Assoc Thai. 2007;90 (7):1382-90. . PubMed PMID:17710981 .
Search PubMed